Natiluzimab therapy: Safe after all?

The efficacy of natiluzimab therapy was established in clinical trials.  It soon, emerged, however that this “life changing” medication was potentially associated with a devastating infectious disorder of the brain, progressive multifocal leucoencephalopathy (PML).  This side-effect resulted in withdrawal of the medication from clinical use for a period of time.  Since re-introduction rigorous screening and […]

Read More…

Perivascular hyperintensities and cognitive impairment: No link

The detection of T2 hyperintensities within the CNS, often termed small vessel disease, has been linked to development of cognitive impairment and is though to be driven by vascular risk factors such as hypertension.  MRI-visible perivascular spaces (PVS), see fig below, appear to be reliable MRI bio-markers of small vessel disease and have been associated […]

Read More…

To MOTYB or not to MOTYB?

Assessment of delirium in the elderly is paramount for appropriate & effective management of in-patients.  A bed-side test that quickly and reliably  ascertains delirium is important, especially in a busy hospital environment.  Once diagnosed, appropriate investigations could be instigated and management implemented.  In an upcoming issue of JNNP, O’Regan and colleagues establish a potential diagnostic […]

Read More…